Catalyst Wire Dossier Catalyst Wire Dossier

Norovirus G1.1/G2.4 oral vaccine

· Vaxart, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Norovirus G1.1/G2.4 oral vaccine, covering 2025-04-29 to 2025-04-29. Get the full timeline:

Most recent: Clinical Trial Update: A Trial of a Norovirus G1.1 and G2.4 Vaccine Administered Orally to Healthy Participants Aged ≥ 18 Years and ≤ 80 Years Old [Phase 1]

See pricing